68.00
price down icon4.12%   -2.92
pre-market  Pre-mercato:  67.51   -0.49   -0.72%
loading
Precedente Chiudi:
$70.92
Aprire:
$70.82
Volume 24 ore:
1.00M
Relative Volume:
2.01
Capitalizzazione di mercato:
$4.87B
Reddito:
-
Utile/perdita netta:
$-224.29M
Rapporto P/E:
-17.44
EPS:
-3.9
Flusso di cassa netto:
$-185.06M
1 W Prestazione:
-9.31%
1M Prestazione:
-9.31%
6M Prestazione:
-33.99%
1 anno Prestazione:
-11.79%
Intervallo 1D:
Value
$67.80
$72.61
Intervallo di 1 settimana:
Value
$67.47
$77.92
Portata 52W:
Value
$61.80
$113.51

Nuvalent Inc Stock (NUVL) Company Profile

Name
Nome
Nuvalent Inc
Name
Telefono
508-446-2272
Name
Indirizzo
ONE BROADWAY, 14TH FLOOR, CAMBRIDGE
Name
Dipendente
142
Name
Cinguettio
Name
Prossima data di guadagno
Name
Ultimi documenti SEC
Name
NUVL's Discussions on Twitter

Confronta NUVL con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
NUVL
Nuvalent Inc
68.00 4.87B 0 -224.29M -185.06M -3.90
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
484.74 124.48B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
617.00 67.45B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
567.09 34.59B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
255.76 33.10B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
271.04 29.15B 3.81B -644.79M -669.77M -6.24

Nuvalent Inc Stock (NUVL) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-03-14 Aggiornamento UBS Neutral → Buy
2024-12-30 Iniziato H.C. Wainwright Buy
2024-10-24 Iniziato UBS Neutral
2024-08-29 Iniziato Barclays Overweight
2024-04-17 Iniziato Jefferies Buy
2024-04-01 Aggiornamento Leerink Partners Market Perform → Outperform
2024-02-28 Ripresa Guggenheim Buy
2024-02-23 Iniziato Robert W. Baird Outperform
2023-09-27 Iniziato Stifel Buy
2023-08-08 Iniziato SVB Securities Market Perform
2023-07-24 Iniziato Guggenheim Buy
2023-01-18 Iniziato Wedbush Outperform
2022-06-24 Iniziato BMO Capital Markets Outperform
Mostra tutto

Nuvalent Inc Borsa (NUVL) Ultime notizie

pulisher
Apr 01, 2025

(NUVL) On The My Stocks Page - news.stocktradersdaily.com

Apr 01, 2025
pulisher
Apr 01, 2025

Is Nuvalent (NUVL) the Best Debt Free Mid Cap Stock to Buy Now? - Yahoo Finance

Apr 01, 2025
pulisher
Apr 01, 2025

Exclusive: Nuvalent CEO to Share Latest Cancer Treatment Innovation Strategy at Stifel Forum - Stock Titan

Apr 01, 2025
pulisher
Apr 01, 2025

Nuvalent, Inc. (NASDAQ:NUVL) Receives Consensus Recommendation of “Moderate Buy” from Analysts - Defense World

Apr 01, 2025
pulisher
Mar 30, 2025

Nuvalent, Inc. (NASDAQ:NUVL) Stake Cut by Virtu Financial LLC - MarketBeat

Mar 30, 2025
pulisher
Mar 30, 2025

Teacher Retirement System of Texas Boosts Holdings in Nuvalent, Inc. (NASDAQ:NUVL) - Defense World

Mar 30, 2025
pulisher
Mar 29, 2025

Why Nuvalent (NUVL) Is Among the Best Mid Cap Biotech Stocks to Buy - Insider Monkey

Mar 29, 2025
pulisher
Mar 29, 2025

Nuvalent chief development officer sells shares worth $292,468 By Investing.com - Investing.com Philippines

Mar 29, 2025
pulisher
Mar 28, 2025

Nuvalent chief development officer sells shares worth $292,468 - Investing.com India

Mar 28, 2025
pulisher
Mar 26, 2025

10 Best Mid Cap Biotech Stocks to Buy - Insider Monkey

Mar 26, 2025
pulisher
Mar 25, 2025

Nuvalent to Present New Preclinical Data on ALK-Selective Inhibitor, Neladalkib, and ROS1-Selective Inhibitor, Zidesamtinib, at AACR Annual Meeting 2025 - Nasdaq

Mar 25, 2025
pulisher
Mar 25, 2025

Breakthrough Cancer Drug Data: New Brain-Penetrant Therapy Shows Promise Against Resistant Tumors - Stock Titan

Mar 25, 2025
pulisher
Mar 24, 2025

Connor Clark & Lunn Investment Management Ltd. Sells 18,609 Shares of Nuvalent, Inc. (NASDAQ:NUVL) - MarketBeat

Mar 24, 2025
pulisher
Mar 22, 2025

How the (NUVL) price action is used to our Advantage - news.stocktradersdaily.com

Mar 22, 2025
pulisher
Mar 21, 2025

Raymond James Financial Inc. Acquires Shares of 133,964 Nuvalent, Inc. (NASDAQ:NUVL) - Defense World

Mar 21, 2025
pulisher
Mar 19, 2025

Nuvalent CEO Porter sells $2.05 million in stock By Investing.com - Investing.com Australia

Mar 19, 2025
pulisher
Mar 19, 2025

Nuvalent CEO Porter sells $2.05 million in stock - Investing.com

Mar 19, 2025
pulisher
Mar 19, 2025

Victory Capital Management Inc. Cuts Stock Position in Nuvalent, Inc. (NASDAQ:NUVL) - Defense World

Mar 19, 2025
pulisher
Mar 19, 2025

Charles Schwab Investment Management Inc. Buys 7,742 Shares of Nuvalent, Inc. (NASDAQ:NUVL) - Defense World

Mar 19, 2025
pulisher
Mar 18, 2025

US Bancorp DE Invests $90,000 in Nuvalent, Inc. (NASDAQ:NUVL) - Defense World

Mar 18, 2025
pulisher
Mar 15, 2025

Bank of New York Mellon Corp Increases Holdings in Nuvalent, Inc. (NASDAQ:NUVL) - Defense World

Mar 15, 2025
pulisher
Mar 14, 2025

UBS Upgrades Nuvalent (NUVL) - Nasdaq

Mar 14, 2025
pulisher
Mar 14, 2025

Nuvalent upgraded to Buy from Neutral at UBS - TipRanks

Mar 14, 2025
pulisher
Mar 14, 2025

UBS Upgrades Nuvalent to Buy From Neutral, Maintains $100 Price Target -March 14, 2025 at 07:24 am EDT - Marketscreener.com

Mar 14, 2025
pulisher
Mar 08, 2025

Principal Financial Group Inc. Cuts Position in Nuvalent, Inc. (NASDAQ:NUVL) - Defense World

Mar 08, 2025
pulisher
Mar 07, 2025

Nuvalent, Inc. (NASDAQ:NUVL) Receives Consensus Rating of “Moderate Buy” from Analysts - Defense World

Mar 07, 2025
pulisher
Mar 06, 2025

HC Wainwright Has Negative Forecast for Nuvalent Q1 Earnings - Defense World

Mar 06, 2025
pulisher
Mar 04, 2025

Nuvalent’s (NUVL) Buy Rating Reaffirmed at HC Wainwright - Defense World

Mar 04, 2025
pulisher
Mar 03, 2025

H.C. Wainwright maintains Buy on Nuvalent stock, $110 target By Investing.com - Investing.com Canada

Mar 03, 2025
pulisher
Mar 03, 2025

New York State Common Retirement Fund Sells 2,495 Shares of Nuvalent, Inc. (NASDAQ:NUVL) - Defense World

Mar 03, 2025
pulisher
Mar 01, 2025

Where are the Opportunities in (NUVL) - news.stocktradersdaily.com

Mar 01, 2025
pulisher
Mar 01, 2025

Rhumbline Advisers Has $3.95 Million Stake in Nuvalent, Inc. (NASDAQ:NUVL) - Defense World

Mar 01, 2025
pulisher
Feb 28, 2025

Nuvalent’s Strategic Advances in NSCLC Trials Justify Buy Rating - TipRanks

Feb 28, 2025
pulisher
Feb 28, 2025

Nuvalent to Participate in Upcoming March Investor Conferences - Citizentribune

Feb 28, 2025
pulisher
Feb 28, 2025

Nuvalent, Inc. Reports 2024 Financial Results and Pipeline Progress - TipRanks

Feb 28, 2025
pulisher
Feb 27, 2025

Nuvalent Outlines Pipeline and Business Progress, Reiterates Key Anticipated Milestones, and Reports Fourth Quarter and Full Year 2024 Financial Results - The Malaysian Reserve

Feb 27, 2025
pulisher
Feb 27, 2025

Nuvalent's Q4 Net Loss Widens -February 27, 2025 at 07:14 am EST - Marketscreener.com

Feb 27, 2025
pulisher
Feb 27, 2025

Earnings Flash (NUVL) Nuvalent Posts Q4 Net Loss $1.05 a Share, vs. FactSet Est of $1.08 Loss - Marketscreener.com

Feb 27, 2025
pulisher
Feb 27, 2025

Nuvalent, Inc. SEC 10-K Report - TradingView

Feb 27, 2025
pulisher
Feb 26, 2025

Nuvalent director Shair sells $156,863 in class A common stock By Investing.com - Investing.com Australia

Feb 26, 2025
pulisher
Feb 26, 2025

State of New Jersey Common Pension Fund D Has $1.81 Million Stock Holdings in Nuvalent, Inc. (NASDAQ:NUVL) - Defense World

Feb 26, 2025
pulisher
Feb 26, 2025

Nuvalent director Shair sells $156,863 in class A common stock - Investing.com India

Feb 26, 2025
pulisher
Feb 24, 2025

Can This Biotech Executive's $6.3B Deal Experience Transform Climb Bio's Future? - Stock Titan

Feb 24, 2025
pulisher
Feb 23, 2025

Nuvalent (NUVL) Projected to Post Earnings on Tuesday - Defense World

Feb 23, 2025
pulisher
Feb 21, 2025

Nuvalent CEO sells stock worth over $2.1 million By Investing.com - Investing.com South Africa

Feb 21, 2025
pulisher
Feb 21, 2025

Nuvalent CEO sells stock worth over $2.1 million - Investing.com India

Feb 21, 2025
pulisher
Feb 18, 2025

(NUVL) Proactive Strategies - Stock Traders Daily

Feb 18, 2025
pulisher
Feb 18, 2025

Nuvalent (NUVL) Projected to Post Quarterly Earnings on Tuesday - MarketBeat

Feb 18, 2025
pulisher
Feb 14, 2025

Nuvalent, Inc. (NASDAQ:NUVL) Receives $112.36 Consensus Target Price from Analysts - MarketBeat

Feb 14, 2025
pulisher
Feb 13, 2025

Q1 Earnings Estimate for Nuvalent Issued By Leerink Partnrs - MarketBeat

Feb 13, 2025
pulisher
Feb 13, 2025

abrdn plc Buys 9,241 Shares of Nuvalent, Inc. (NASDAQ:NUVL) - MarketBeat

Feb 13, 2025

Nuvalent Inc Azioni (NUVL) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$67.94
price down icon 3.89%
$72.00
price down icon 5.62%
$31.17
price up icon 0.13%
$18.80
price down icon 2.54%
$90.29
price down icon 0.85%
biotechnology ONC
$271.04
price down icon 0.42%
Capitalizzazione:     |  Volume (24 ore):